Skye Bioscience Inc (OTCMKTS:SKYE) Stock Down 17% in a Week: What’s The Buzz?
There have been many stocks which have not performed particularly well over the course of the past week and one of those is that of Skye Bioscience Inc (OTCMKTS:SKYE). The company, which is involved in the development of proprietary CBD based molecular for treating diseases with considerable unmet need, has seen its stock decline by as much as 17% over the past week. Yesterday, the company was in the news…